{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T13:16:22Z","timestamp":1795180582180,"version":"4.10.3"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"British Heart Foundation (BHF) Clinical Research Training Fellowship","award":["FS 18\/16\/33396"],"award-info":[{"award-number":["FS 18\/16\/33396"]}]},{"name":"British Heart Foundation Centre of Research Excellence at King\u2019s College London","award":["RE16349"],"award-info":[{"award-number":["RE16349"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with ischaemic left ventricular dysfunction frequently undergo myocardial viability testing. The historical model presumes that those who have extensive areas of dysfunctional-yet-viable myocardium derive particular benefit from revascularization, whilst those without extensive viability do not. These suppositions rely on the theory of hibernation and are based on data of low quality: taking a dogmatic approach may therefore lead to patients being refused appropriate, prognostically important treatment. Recent data from a sub-study of the randomized STICH trial challenges these historical concepts, as the volume of viable myocardium failed to predict the effectiveness of coronary artery bypass grafting. Should the Heart Team now abandon viability testing, or are new paradigms needed in the way we interpret viability? This state-of-the-art review critically examines the evidence base for viability testing, focusing in particular on the presumed interactions between viability, functional recovery, revascularization and prognosis which underly the traditional model. We consider whether viability should relate solely to dysfunctional myocardium or be considered more broadly and explore wider uses of viability testingoutside of revascularization decision-making. Finally, we look forward to ongoing and future randomized trials, which will shape evidence-based clinical practice in the future.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehab729","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T20:47:30Z","timestamp":1633034850000},"page":"118-126","source":"Crossref","is-referenced-by-count":62,"title":["Myocardial viability testing: all STICHed up, or about to be REVIVED?"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8256-195X","authenticated-orcid":false,"given":"Matthew","family":"Ryan","sequence":"first","affiliation":[{"name":"School of Cardiovascular Medicine and Sciences, King\u2019s College London , Westminster Bridge Road, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-6174","authenticated-orcid":false,"given":"Holly","family":"Morgan","sequence":"additional","affiliation":[{"name":"School of Cardiovascular Medicine and Sciences, King\u2019s College London , Westminster Bridge Road, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Chiribiri","sequence":"additional","affiliation":[{"name":"School of Biomedical Engineering and Imaging Sciences, King\u2019s College London , Westminster Bridge Road, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-950X","authenticated-orcid":false,"given":"Eike","family":"Nagel","sequence":"additional","affiliation":[{"name":"Institute for Experimental and Translational Cardiovascular Imaging, DZHK Centre for Cardiovascular Imaging, University Hospital Frankfurt , Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-7016","authenticated-orcid":false,"given":"John","family":"Cleland","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics, University of Glasgow , University Avenue, Glasgow G12 8QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6362-1291","authenticated-orcid":false,"given":"Divaka","family":"Perera","sequence":"additional","affiliation":[{"name":"School of Cardiovascular Medicine and Sciences, King\u2019s College London , Westminster Bridge Road, London SE1 7EH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,13]]},"reference":[{"key":"2022102517040118100_ehab729-B1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ehf2.12019","article-title":"Predictive power of late gadolinium enhancement for myocardial recovery in chronic ischaemic heart failure: a HEART sub-study","volume":"1","author":"McDiarmid","year":"2014","journal-title":"ESC Heart Fail"},{"key":"2022102517040118100_ehab729-B2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMoa1807365","article-title":"Myocardial viability and long-term outcomes in ischemic cardiomyopathy","volume":"381","author":"Panza","year":"2019","journal-title":"N Engl J Med"},{"key":"2022102517040118100_ehab729-B4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/eurjhf\/hfq230","article-title":"The Heart Failure Revascularisation Trial (HEART)","volume":"13","author":"Cleland","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2022102517040118100_ehab729-B5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0735-1097(01)01766-1","article-title":"The histology of viable and hibernating myocardium in relation to imaging characteristics","volume":"39","author":"Gunning","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.yjmcc.2011.08.019","article-title":"Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease","volume":"52","author":"Canty","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"2022102517040118100_ehab729-B7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11897-018-0396-6","article-title":"Identifying and managing hibernating myocardium: what's new and what remains unknown?","volume":"15","author":"Ryan","year":"2018","journal-title":"Curr Heart Fail Rep"},{"key":"2022102517040118100_ehab729-B8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-8703(89)90685-6","article-title":"The hibernating myocardium","volume":"117","author":"Rahimtoola","year":"1989","journal-title":"Am Heart J"},{"key":"2022102517040118100_ehab729-B9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cpcardiol.2007.04.001","article-title":"Hibernating myocardium: diagnosis and patient outcomes","volume":"32","author":"Schinkel","year":"2007","journal-title":"Curr Probl Cardiol"},{"key":"2022102517040118100_ehab729-B10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/01.CIR.98.11.1078","article-title":"Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study","volume":"98","author":"Picano","year":"1998","journal-title":"Circulation"},{"key":"2022102517040118100_ehab729-B11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(03)13801-9","article-title":"Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial","volume":"362","author":"Cleland","year":"2003","journal-title":"Lancet"},{"key":"2022102517040118100_ehab729-B12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/eurheartj\/ehl379","article-title":"Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients","volume":"28","author":"Ypenburg","year":"2006","journal-title":"Eur Heart J"},{"key":"2022102517040118100_ehab729-B13","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jcin.2018.05.041","article-title":"A Randomized trial to assess regional left ventricular function after stent implantation in chronic total occlusion: the REVASC trial","volume":"11","author":"Mashayekhi","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102517040118100_ehab729-B14","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2016.07.744","article-title":"Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial","volume":"68","author":"Henriques","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamacardio.2016.1325","article-title":"Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction","volume":"1","author":"Kalogeropoulos","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2022102517040118100_ehab729-B16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.hrthm.2013.02.017","article-title":"Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE)","volume":"10","author":"Schliamser","year":"2013","journal-title":"Heart Rhythm"},{"key":"2022102517040118100_ehab729-B17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0735-1097(03)00789-7","article-title":"The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure","volume":"42","author":"Curtis","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B18","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1136\/hrt.2009.173302","article-title":"Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study","volume":"95","author":"Rahimi","year":"2009","journal-title":"Heart"},{"key":"2022102517040118100_ehab729-B19","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/eurheartj\/ehn266","article-title":"Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study","volume":"29","author":"Bondarenko","year":"2008","journal-title":"Eur Heart J"},{"key":"2022102517040118100_ehab729-B20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/heartjnl-2020-316975","article-title":"Improvement of ejection fraction and mortality in ischaemic heart failure","volume":"107","author":"Perry","year":"2021","journal-title":"Heart"},{"key":"2022102517040118100_ehab729-B21","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"2022102517040118100_ehab729-B22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102517040118100_ehab729-B23","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/CIRCULATIONAHA.116.024800","article-title":"Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH trial (Surgical Treatment for Ischemic Heart Failure)","volume":"134","author":"Petrie","year":"2016","journal-title":"Circulation"},{"key":"2022102517040118100_ehab729-B24","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2015.08.882","article-title":"Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH","volume":"66","author":"Jolic\u0153ur","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B25","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.jacc.2013.02.014","article-title":"Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction","volume":"61","author":"Panza","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B26","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med"},{"key":"2022102517040118100_ehab729-B27","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)","volume":"50","author":"Beanlands","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jcmg.2009.02.017","article-title":"Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial","volume":"2","author":"D'Egidio","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022102517040118100_ehab729-B29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jchf.2013.04.012","article-title":"The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results","volume":"1","author":"Carson","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2022102517040118100_ehab729-B30","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1093\/eurheartj\/ehz409","article-title":"The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization","volume":"40","author":"Cleland","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102517040118100_ehab729-B31","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jcmg.2016.01.033","article-title":"Myocardial fibrosis assessment by LGE is a powerful predictor of ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis","volume":"9","author":"Disertori","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022102517040118100_ehab729-B32","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"2022102517040118100_ehab729-B33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmg.2017.04.021","article-title":"Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patients with cardiac resynchronization therapy: the GAUDI-CRT study","volume":"11","author":"Acosta","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022102517040118100_ehab729-B34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fphys.2020.00933","article-title":"Body surface mapping of ventricular repolarization heterogeneity: an ex-vivo multiparameter study","volume":"11","author":"Meo","year":"2020","journal-title":"Front Physiol"},{"key":"2022102517040118100_ehab729-B35","first-page":"3","article-title":"Mechanisms of ventricular arrhythmias in acute ischemia and reperfusion","volume":"22","author":"Sedlis","year":"1992","journal-title":"Cardiovasc Clin"},{"key":"2022102517040118100_ehab729-B36","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/01.RES.0000125628.57672.CF","article-title":"Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death","volume":"94","author":"Canty","year":"2004","journal-title":"Circ Res"},{"key":"2022102517040118100_ehab729-B37","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.4244\/EIJ-D-18-01117","article-title":"Chronic total coronary occlusion revascularisation positively modifies infarct-related myocardial scar responsible for recurrent ventricular tachycardia","volume":"16","author":"Myat","year":"2021","journal-title":"EuroIntervention"},{"key":"2022102517040118100_ehab729-B38","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jelectrocard.2018.07.012","article-title":"The effect of revascularization of a chronic total coronary occlusion on electrocardiographic variables. A sub-study of the EXPLORE trial","volume":"51","author":"van Dongen","year":"2018","journal-title":"J Electrocardiol"},{"key":"2022102517040118100_ehab729-B39","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/eurheartj\/ehp125","article-title":"Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy","volume":"30","author":"Carluccio","year":"2009","journal-title":"Eur Heart J"},{"key":"2022102517040118100_ehab729-B40","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jacc.2005.09.064","article-title":"Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling","volume":"47","author":"Carluccio","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/hrt.2004.055798","article-title":"Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation","volume":"92","author":"Rizzello","year":"2006","journal-title":"Heart"},{"key":"2022102517040118100_ehab729-B42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0002-9149(02)02190-2","article-title":"Usefulness of rest and low-dose dobutamine wall motion scores in predicting survival and benefit from revascularization in patients with ischemic cardiomyopathy","volume":"89","author":"Sawada","year":"2002","journal-title":"Am J Cardiol"},{"key":"2022102517040118100_ehab729-B43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12968-015-0124-2","article-title":"Feasibility of high-resolution quantitative perfusion analysis in patients with heart failure","volume":"17","author":"Sammut","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022102517040118100_ehab729-B44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/01.CIR.100.2.141","article-title":"Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction","volume":"100","author":"Pasquet","year":"1999","journal-title":"Circulation"},{"key":"2022102517040118100_ehab729-B45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ahj.2012.05.018","article-title":"Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention","volume":"164","author":"Shaw","year":"2012","journal-title":"Am Heart J"},{"key":"2022102517040118100_ehab729-B46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102517040118100_ehab729-B47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.nuclcard.2006.08.017","article-title":"Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary?","volume":"13","author":"Hachamovitch","year":"2006","journal-title":"J Nucl Cardiol"},{"key":"2022102517040118100_ehab729-B48","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehq500","article-title":"Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy","volume":"32","author":"Hachamovitch","year":"2011","journal-title":"Eur Heart J"},{"key":"2022102517040118100_ehab729-B49","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacep.2018.06.002","article-title":"Myocardial scar but not ischemia is associated with defibrillator shocks and sudden cardiac death in stable patients with reduced left ventricular ejection fraction","volume":"4","author":"Gupta","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2022102517040118100_ehab729-B50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCIMAGING.112.000138","article-title":"Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium","volume":"6","author":"Ling","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022102517040118100_ehab729-B51","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.120.050304","article-title":"Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction: insights from the ISCHEMIA trial","volume":"142","author":"Lopes","year":"2020","journal-title":"Circulation"},{"key":"2022102517040118100_ehab729-B52","doi-asserted-by":"crossref","first-page":"e012319","DOI":"10.1161\/CIRCIMAGING.120.012319","article-title":"ISCHEMIA trial: are we still fighting the last war?","volume":"14","author":"Hachamovitch","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022102517040118100_ehab729-B53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","article-title":"Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals","volume":"391","author":"Conrad","year":"2018","journal-title":"Lancet"},{"key":"2022102517040118100_ehab729-B54","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jacc.2012.08.1034","article-title":"The Heart Team of cardiovascular care","volume":"61","author":"Holmes","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","journal-title":"Lancet"},{"key":"2022102517040118100_ehab729-B56","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0735-1097(01)01118-4","article-title":"Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure","volume":"37","author":"Kj\u00f8ller-Hansen","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3109\/10641969509033651","article-title":"Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykinin","volume":"17","author":"Ruocco","year":"1995","journal-title":"Clin Exp Hypertens"},{"key":"2022102517040118100_ehab729-B58","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0002-8703(91)90134-4","article-title":"Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action","volume":"121","author":"Przyklenk","year":"1991","journal-title":"Am Heart J"},{"key":"2022102517040118100_ehab729-B59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCINTERVENTIONS.110.960476","article-title":"Pilot study to assess whether glucagon-like peptide-1 protects the heart from ischemic dysfunction and attenuates stunning after coronary balloon occlusion in humans","volume":"4","author":"Read","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"2022102517040118100_ehab729-B60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.108.188730","article-title":"Pravastatin improves function in hibernating myocardium by mobilizing CD133+ and cKit+ bone marrow progenitor cells and promoting myocytes to reenter the growth phase of the cardiac cell cycle","volume":"104","author":"Suzuki","year":"2009","journal-title":"Circ Res"},{"key":"2022102517040118100_ehab729-B61","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2006.11.047","article-title":"Endothelial nitric oxide synthase overexpression provides a functionally relevant angiogenic switch in hibernating pig myocardium","volume":"49","author":"Kupatt","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102517040118100_ehab729-B62","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jchf.2018.01.024","article-title":"Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial: percutaneous coronary intervention for ischemic cardiomyopathy","volume":"6","author":"Perera","year":"2018","journal-title":"JACC Heart Fail"},{"key":"2022102517040118100_ehab729-B63","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/1745-6215-14-218","article-title":"Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial","volume":"14","author":"O'Meara","year":"2013","journal-title":"Trials"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/2\/118\/46629723\/ehab729.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/2\/118\/46629723\/ehab729.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T18:19:53Z","timestamp":1666721993000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/2\/118\/6427439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,13]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,11,13]]},"published-print":{"date-parts":[[2022,1,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab729","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,7]]},"published":{"date-parts":[[2021,11,13]]}}}